26 C
Vientiane
Tuesday, May 13, 2025
spot_img
Home Blog Page 635

Nozomi Networks Named a Leader in the 2025 Gartner® Magic Quadrant™ for CPS Protection Platforms

Company Recognized for Ability to Execute, and Completeness of Vision

SAN FRANCISCO, Feb. 19, 2025 /PRNewswire/ — Nozomi Networks, the leader in OT, IoT and CPS security, today announced it has been named a Leader in the 2025 Gartner® Magic Quadrant™ for CPS Protection Platforms.

According to Gartner, cyber-physical systems (CPS) protection platforms vendors offer products and services that use knowledge of industrial protocols, operational/production network packets or traffic metadata, and physical process asset behavior to discover, categorize, map and protect cyber-physical systems in production or mission-critical environments outside of enterprise IT. Gartner also noted that, “cyber-physical systems protection platforms that discover and protect assets in production or mission-critical environments are emerging as a leading market category.”

“We are honored that Gartner has recognized Nozomi Networks as a Leader in its first Magic Quadrant for CPS protection platforms,” said CEO Edgard Capdevielle. “We believe this recognition demonstrates Nozomi’s capabilities in leveraging AI for asset discovery as well as threat and vulnerability management, and it underscores our longstanding commitment to innovation and partnership with our customers. We are dedicated to empowering organizations with better ways to secure critical infrastructure, mitigating risk and maximizing resilience from the endpoint to the air.”

Read the 2025 Gartner® Magic Quadrant™ for CPS Protection Platforms here.

Since 2013, Nozomi Networks has been a pioneer in OT, IoT and cyber-physical systems security. Our people, partners and fully integrated, AI-powered CPS protection platform deliver unmatched visibility, proactive threat detection, and real-time insights.

With the Nozomi Networks Platform, CISOs and their security teams benefit from:

  • Unparalleled asset discovery and inventory across wired, wireless, endpoint and ICS endpoint attack surfaces
  • Sophisticated, actionable vulnerability management
  • Fast and accurate anomaly and threat detection and management
  • A comprehensive view of CPS cyber risk and risk mitigation strategies from the asset to the enterprise
  • AI-powered prioritizations and remediation recommendations

The platform excels at delivering operational resilience, risk management and regulatory compliance outcomes to customers across a wide array of OT and IoT verticals and use cases.

Nozomi Networks helps customers in six continents around the world manage risk and maximize resilience at every stage of their digital journey. In addition to being recognized as a Leader in the 2025 Gartner Magic Quadrant, Nozomi Networks is rated 4.9 based on 126 reviews as of 14 February 2025 in Gartner Peer Insight Reviews for OT Security. 

According to the OT Cybersecurity Manager of IT Security and Risk Management for an energy and utility company, “The solutions provided by Nozomi proved to be the best choice possible to protect and monitor our industrial sites. Through its installation in our plants, we are obtaining a complete overview of the industrial assets and are able to find out in real time threats, vulnerabilities and any kind of noncompliance – being able to control that any control and maintenance activity is properly traced, be that performed locally or remotely.”

And the Cyber Security Engineer of IT Security and Risk Management for a real estate company said, “Nozomi is a powerful and flexible tool that offers significant value to organizations looking to enhance their security posture. They have excellent support, high customizability, and strong incident management capabilities. It is without a doubt well-suited for any organization with complex and evolving security needs.”

To learn more about Nozomi Networks and the Nozomi Networks Platform:

  • Read our BlogNozomi Networks Is a Leader in 2025 Gartner® Magic Quadrant™ for CPS Protection Platforms 
  • Sign up for a live demo

Gartner, Magic Quadrant for CPS Protection Platforms, Katell Thielemann, Wam Voster, Ruggero Contu, 12 February 2025

Gartner does not endorse any vendor, product or service depicted in our research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and Magic Quadrant and Peer Insights are registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

About Nozomi Networks
Nozomi Networks protects the world’s critical infrastructure from cyber threats. Our platform uniquely combines network and endpoint visibility, threat detection, and AI-powered analysis for faster, more effective incident response. Customers rely on us to minimize risk and complexity while maximizing operational resilience. www.nozominetworks.com

Logo – https://laotiantimes.com/wp-content/uploads/2025/02/nozomi_networks_logo.jpg

Join WEPACK 2025 – Embark on an Overseas Packaging Exploration Journey

SHANGHAI, Feb. 19, 2025 /PRNewswire/ — With the rapid rise of China’s manufacturing industry, the packaging sector in China has been developing at an increasingly swift pace. Many outstanding companies have emerged, standing out with advanced equipment, high production efficiency, and competitive pricing, earning recognition from global peers. Currently, China holds a 23% share of the global packaging market, with a sales revenue of $266.1 billion.

As a premier global packaging event, WEPACK, organized by RX, showcases leading enterprises across the entire packaging value chain, from raw materials and processing equipment to production processes and finished products. Each edition attracts nearly 10,000 overseas packaging companies, agents, and associations from over 110 countries and regions, covering sectors such as corrugated boxes, folding carton boxes, printing, and food packaging. These participants not only seek trade partnerships but also aim to learn advanced technologies and innovative concepts from Chinese enterprises.

To strengthen the communication bridge between overseas attendees and Chinese enterprises, WEPACK 2025 will launch the Overseas Packaging Enterprises’ Business Study Tour to China. The organizers of this event will collaborate with outstanding exhibitors from East China, South China, and North China to design 6 customized routes based on market segmentation. These routes include: Intelligent Factory Visit Study Tour; Lean Management; Food Container Processing and Pulp Molding Visit Study Tour; Digital Packaging Study Tour; Lean Production Study Tour; Large-format Carton Forming Packaging Study Tour. Each group will have a capacity of 30 participants.


The research tour will take place from April 6 to 13, 2025. Exhibitor companies participating in the factory showcase will be equipped with senior executives and English-speaking guides. Through a variety of engaging activities, including factory tours, hands-on demonstrations, closed-door forums, and business cocktail receptions, overseas attendees will have the opportunity for close and direct interaction and exchange throughout the event.

Time planning

Date

Activity Arrangement

April 6

Arrival in Shanghai, China

April 7

Attend the World Corrugated Forum (WCF)

April 8-10

Participate in WEPACK 2025

April 11-13

Overseas Business Study Tour

Route 1: East China Route – Intelligent Factory Visit Study Tour (1 Day)

Content: Explore how Chinese carton enterprises build and upgrade into intelligent plants, hence efficiently operating and rapidly expanding capacity to ensure enterprise competitiveness.

Visiting enterprises: 
LD Intelligent Technology Co., Ltd.
Shanghai Dinglong Machinery Co., Ltd.
BHS Corrugated Machinery (Shanghai) Co., Ltd.

Route 2: East China RouteLean-based management (1 Day)

Content: Understand how Chinese carton enterprises maintain advantages and high profitability in a fiercely competitive market through lean management.

Visiting enterprises: 
Nantong Zhongtai Paper Products Co., Ltd.
TAT SENG PACKAGING GROUP LTD
Jiangsu Xutian Environmental Protection Machinery Co., Ltd.

Route 3: East China RouteFood Paper Container and Pulp Molding Packaging Advanced Factory Study Group (2 Days)

Content: Discover the core market of China’s highly developed and thriving food container packaging industry, how packaging enterprises innovate R&D and upgrade technologies to expand new tracks and markets, and explore the latest pulp molding cutting-edge trends and core technologies.

Visiting enterprises: 
Zhejiang One Joy Intelligent Packaging Technology Co., LTD
Zhejiang Discover Machinery Manufacturing Co., Ltd
Zhejiang Fulai New Materials Co., Ltd.

Route 4: South China Route – Digital Printing and Smart Factory Study Tour Group (2 Days)

Content: Learn how Chinese carton enterprises expand new tracks and new businesses through digital technologies and achieve green, sustainable development.

Visiting enterprises: 
Shantou Lexiang Packaging Co., Ltd.
Chaozhou Shengshuo Carton Factory

Route 5: South China Route – Guangdong Lean Factory Management Study Tour Group (2 Days)

Content: Understand how Chinese carton enterprises maintain advantages and high profitability in a fiercely competitive market through lean management.

Visiting enterprises:
Amcor Flexible Packaging (Zhongshan) Co., Ltd.
Foshan Ever Young Paper Products Co., Ltd.

Route 6: North China Route Large Format Corrugated Board/Carton Molding Packaging Study Group (3 Days) 

Content: Explore how Chinese carton enterprises prioritizing large-format long-term orders maintain capacity, control costs, improve efficiency, and realize long-range enterprise development strategies.

Visiting enterprises:
Langfang Santai Paper Co., Ltd.
Zhongrong Printing Group
Shengda Printing
Masterwork Group Co., Ltd

This “overseas packaging enterprises’ Business Study Tour to China” not only provides overseas packaging enterprises with a platform to deeply understand the Chinese market but also offers Chinese packaging enterprises an opportunity to showcase their superior products and broaden their international horizon. It is believed that through this campaign, both parties will gain more inspiration and inject new vitality into the global packaging industry’s development. We look forward to your participation!

If you have any questions, please contact:
Alan Li
Phone:+86-021-2231 7155
WhatsApp:+86 158 9757 6857
Email: alan.li@rxglobal.com

Tips: Please note that as this is a business program, the final factory visit is subject to the site, and we try to ensure that it is a current Factory.

AESOP Technology Unveils World’s First Machine Learning Model to Combat Wrong-Site Surgery

SAN FRANCISCO, Feb. 19, 2025 /PRNewswire/ — Wrong-site surgery (WSS), a critical “Never Event,” represents a failure that should never occur in healthcare. Yet, due to underreporting, the true prevalence of these incidents remains obscured, jeopardizing patient safety and healthcare management. AESOP Technology, a medical AI startup, has developed an innovative solution: the Association Outlier Pattern (AOP) machine learning model. This model offers real-time decision support and retrospective analysis, aimed at enhancing surgical safety and care quality.

According to the World Health Organization’s (WHO) 2024 Patient Safety Report, a mere 38% of countries have established reporting systems for never events. In the United States, the Joint Commission documented 112 surgical errors in 2023, with wrong-site surgeries comprising 62% of these incidents. The absence of comprehensive reporting hinders the healthcare system’s ability to gauge the issue’s magnitude and implement effective preventative measures.

Inconsistent documentation is one of the major contributors to WSS. To address this, AESOP utilized data from the Centers for Medicare & Medicaid Services Limited Data Set (2017–2020), examining discrepancies in surgical laterality. This analysis informed the creation of the AOP model—the first of its kind dedicated to addressing WSS.

Unlike traditional rule-based systems that merely verify consistency, the AOP model analyzes intricate patterns between diagnoses and surgeries. It excels in handling incomplete or ambiguous diagnostic data, achieving an accuracy rate of over 80% in identifying surgical errors, outperforming existing methods.

The AOP model empowers healthcare organizations to detect inconsistencies in medical records, identify unreported surgical errors, and enhance reporting mechanisms. This not only improves patient safety but also strengthens management systems for error prevention.

Beyond retrospective analysis, the AOP model offers real-time decision support during surgical planning. It automatically flags incorrect associations between surgical codes and diagnoses, ensuring accurate and complete records. This real-time capability reduces error risks, making the AOP model an essential tool for future electronic health record (EHR) systems.

“We are thrilled with the preliminary outcomes of our research and look forward to integrating these insights into DxPrime’s patient safety features this year,” said Jim Long, CEO of AESOP Technology. “Our advancements in automating surgery coding show great potential for helping physicians deliver safer care, reduce documentation time, and enable medical coders to perform better concurrent surgery coding and review when patients are still hospitalized.”

Having demonstrated its efficacy in orthopedics, the AOP model holds promise for other specialties reliant on laterality, such as ophthalmology and otolaryngology. This expansion aligns with AESOP’s commitment to advancing patient-centered AI solutions across diagnostics, medication safety, and now surgical safety—ushering in a new era of reliable and safer healthcare.

About AESOP Technology

AESOP Technology harnesses the power of AI to revolutionize clinical decision-making through its Clinical Diagnostic Reasoning Network model. By enhancing the accuracy of diagnoses, medication prescriptions, and medical coding, AESOP aims to improve patient safety and streamline healthcare processes. Its innovative solutions seamlessly integrate with EHR systems to boost efficiency and minimize errors, setting a new standard in medical care.

BNH Hospital Goes 100% Paperless with InterSystems TrakCare EMR System

Private hospital in Thailand invests in change management program, engaging clinicians for future technology success

BANGKOK, Feb. 19, 2025 /PRNewswire/ — InterSystems announced that BNH Hospital in Bangkok has gone 100% paperless with a new InterSystems TrakCare® electronic medical record (EMR) system after investing in a change management program involving clinicians and managers. This significant change comes as part of Thailand’s ongoing efforts to modernize healthcare services and enhance patient care through digital transformation.

BNH Hospital building
BNH Hospital building

BNH Hospital, Thailand’s first international private hospital, was founded in 1898. It was acquired by Bangkok Dusit Medical Services (BDMS), the largest private hospital group in Thailand, and is now part of the Samitivej group, includes six other hospitals. By adopting the TrakCare EMR system, Samitivej aims to enhance operational efficiency and facilitate the integration of new technologies, such as advanced data analytics, crucial for clinical decision-making.

Three Samitivej hospitals have used InterSystems TrakCare for nearly a decade, while four others previously used different EMR systems, complicating standardization for effective data analytics. InterSystems collaborated with Samitivej to implement TrakCare across the group, completing the last of the four new installations in April.

The transition to a new system at BNH Hospital, which had a heavily customized previous system, created opportunities for improvement. To ensure clinician adoption, InterSystems partnered with BNH Hospital on a change management program.

The program, led by surgeon and BNH Assistant Hospital Director Dr. Apichai Chaiyaroj, Dr. Natthinee Mattanapojanat, and Ms. Sareeyanan Sasiyabhand, received strong support from hospital executives and engaged clinicians from the start of the TrakCare implementation.

BNH Hospital achieved 100% clinician adoption of TrakCare since its initial implementation in February, surpassing the previous EMR system’s 70% adoption rate. With full adoption, BNH Hospital now enjoys improved access to clinical, operational, and financial data, providing a comprehensive view of patient information. Using the latest version of TrakCare without customizations facilitates future technology innovations and ensures compliance with Thailand’s regulatory requirements.

BNH Hospital’s leadership plans to involve clinicians in exploring additional TrakCare functionalities. Dr. Chaiyaroj emphasized their commitment to a fully paperless environment for inpatients and outpatients, focusing on creating a user-friendly system for doctors. He noted that collaboration with InterSystems has been vital, stating, “We’ve streamlined data entry into TrakCare and will leverage it fully, avoiding unnecessary add-ons.”

Regarding future plans, Dr. Chaiyaroj expressed excitement about engaging clinicians with more TrakCare features. “We’re looking forward to expanding closed-loop medication management, which we’ve successfully piloted, as well as diving into data analytics. We’re also integrating mobile devices, allowing for even greater accessibility for our doctors.”

Luciano Brustia, InterSystems Regional Managing Director, Asia Pacific, remarked, “Our collaboration with BNH Hospital on this change management process has been rewarding. The leadership of Dr. Chaiyaroj and his team has been crucial in ensuring a smooth transition and achieving 100% clinician engagement, a significant milestone for leveraging new technology to enhance patient care.”

Eagle Point Software Officially Recognized as a SOLIDWORKS Solution Partner

DUBUQUE, Iowa, Feb. 18, 2025 /PRNewswire/ — Eagle Point Software, a leader in Learning Management Systems(LMS) and eLearning solutions, announced its official recognition as a SOLIDWORKS Solution Partner. This designation emphasizes Eagle Point’s commitment to delivering learning and development solutions that empower designers, engineers, and manufacturers to maximize the capability of SOLIDWORKS software.

As a SOLIDWORKS Solution Partner, Eagle Point Software joins a select group of technology providers dedicated to enhancing the SOLIDWORKS ecosystem. This partnership will enable SOLIDWORKS users to leverage Eagle Point’s Pinnacle Series learning platform to streamline workflows, improve design efficiency, and accelerate professional development.

“We are honored to be recognized as a SOLIDWORKS Solution Partner,” said Steve Biver, COO at Eagle Point Software. “Through Pinnacle Series’ vast library of in-depth SOLIDWORKS learning content, we provide engineers and designers with the knowledge they need to leverage SOLIDWORKS to its fullest extent. By equipping these professionals with the right skills, we help organizations accelerate product development cycles, reduce costly errors, and bring innovative products to market faster. This partnership aligns with our mission to help professionals harness the full potential of their design tools, ensuring they can work smarter and more efficiently.”

Pinnacle Series, Eagle Point’s learning and productivity platform, offers in-depth online training, workflow optimization, and real-time support for SOLIDWORKS users. With on-demand learning content and customizable training paths, organizations can bridge skill gaps and drive innovation within their teams.

The SOLIDWORKS Solution Partner Program identifies and supports best-in-class technology providers that integrate with and enhance the capabilities of SOLIDWORKS solutions. Eagle Point Software’s inclusion in this program solidifies its position as a trusted provider of learning and productivity solutions tailored to the needs of the SOLIDWORKS community.

For more information about Eagle Point Software and its SOLIDWORKS solutions, visit www.eaglepoint.com.

About Eagle Point

Pinnacle Series creator Eagle Point Software has helped AEC and manufacturing companies work more efficiently since 1983. Based in Dubuque, Iowa, the Pinnacle Series team is comprised of industry experts who deliver the leading development and productivity platform to more than 500,000 global AEC and manufacturing professionals. Pinnacle Series offers a robust library of on-demand software training content, plus knowledge capture and sharing capabilities that ultimately increase efficiency. www.eaglepoint.com; +1 563.556.8392

 

VIVOZON Pharmaceutical Obtains MFDS Approval for UNAFRA Inj.: A Breakthrough Non-Opioid analgesic

SEOUL, South Korea, Feb. 18, 2025 /PRNewswire/ — On February 17, VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024. (active ingredient: Opiranserin HCl), has received approval from the Ministry of Food and Drug Safety (MFDS). With this milestone, UNAFRA Inj. has become the 38th innovative drug in Korea.

UNAFRA Inj., discovered by using the company’s proprietary multi-target drug development platform, is the world’s first non-opioid, non-NSAIDS analgesic. It induces analgesic effect by simultaneously inhibiting Glycine Transporter Type 2 (GlyT2) and Serotonin Receptor 2a (5HT2a), thereby blocking pain signals and transmission synergistically across both the central and peripheral nervous systems.

Previously, VIVOZON Pharmaceutical confirmed the safety and tolerance of the drug and secured statistical significance for efficacy in a domestic Phase 3 clinical trial and applied for new drug application (NDA) from MFDS in November 2023. The efficacy of the drug was confirmed through the primary endpoint Sum of Pain Intensity Difference over 12 Hours (SPID 12), and secondary endpoints including number of Patient-Controlled Analgesia (PCA) requests and opioid consumption over 12 Hours.

This approval marks a breakthrough in the treatment landscape for moderate to severe pain, addressing the high unmet medical needs in a market that previously lacked alternatives to opioid analgesics. UNAFRA Inj. has been hailed as a game changer by the medical community, showing rapid pain relief with fewer side effects and zero risk of addiction compared to existing opioids with severe addiction.

The company emphasized that UNAFRA Inj. stands apart from earlier domestically developed drugs, which were primarily “Best-in-Class” or “Me-Too” drugs mimicking existing treatments. In contrast, UNAFRA Inj. is Korea’s first “First-in-Class” innovative new drug, demonstrating significant advancements in drug development complexity and originality.

Spokesperson from the company states, “We are thrilled to share this groundbreaking approval with our shareholders and investors who have supported us over the years. This milestone will accelerate our plans for product launch and marketing activities.

Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches

ZUG, Switzerland, Feb. 18, 2025 /PRNewswire/ — Berlin Heals Holding AG, a late stage MedTech start up, has developed a breakthrough method and a product for the therapy of heart failure. The product – an electronic device called C-MIC – has already successfully been tested in patients in a pilot study and recently completed enrollment in an International Multi-Center Controlled Randomized Clinical Trial for CE certification. The company will present the new data at upcoming conferences and publish the results soon. With the therapeutic method now well supported, the company is ready to test the next generation technology in less invasive implant approaches.

To reach these next milestones, the company has successfully raised over CHF 7Million from investors in a recently executed financing round. This funding will support First-In-Human studies to evaluate the safety and efficacy of these new approaches to prepare for the large pivotal trial for global regulatory and reimbursement approvals. This funding will also support further development of the product and preparation for CE submission for the first-generation device.

Berlin Heals Holding AG has already demonstrated the unprecedented success of its dilated cardiomyopathy therapy in a first-in-human pilot study. The company recently presented the Long-Term sustainable results of that study in a Late Breaking Clinical Trial session at the Technology and Heart Failure Therapeutics (THT) conference on February 11th in Boston and has plans to publish the results in an upcoming journal.

John Brumfield, Chief Executive Officer, Berlin Heals Holding AG comments:

“We are very grateful to our internal investors that continue to support our mission to heal Heart Failure. We are also excited to welcome our new investors that have joined us on this journey. The results from our early clinical work showed strong potential for this new therapeutic approach. We are excited to share the results of our new Randomized Clinical Trial later this year. This funding round will give us the opportunity to test the method through several new less invasive approaches to determine which technique should be used in our Pivotal Trial for FDA and global market entry.

Dr. Felix Baader, Chairman of the Board, Berlin Heals Holding AG comments:

“I had the pleasure of meeting several patients together with Co-Founder Marko Bagaric from our first two studies and can see the real impact our innovation has had on returning significant quality of life to them. They were so grateful to have their lives back and be active again. With this funding round, we further our progress to impact many more lives ahead.”

Berlin Heals Holding AG is a Swiss joint-stock company founded in 2014. The company has developed a revolutionary implantable device called “C-MIC” (Cardiac Microcurrent), which – by way of a constant electrical microcurrent and the ensuing electrical field – results in a sustainable and swift improvement of outcomes in heart failure patients according to recent studies.

John Brumfield
media@berlinheals.de

 

 

Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports

MILPITAS, Calif., Feb. 18, 2025 /PRNewswire/ — The global semiconductor manufacturing industry closed 2024 with strong fourth quarter results and solid year-on-year (YoY) growth across most of the key industry segments, SEMI announced today in its Q4 2024 publication of the Semiconductor Manufacturing Monitor (SMM) Report, prepared in partnership with TechInsights. The industry outlook is cautiously optimistic at the start of 2025 as seasonality and macroeconomic uncertainty may impede near-term growth despite momentum from strong investments related to AI applications.

Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports
Global Semiconductor Manufacturing Industry Reports Solid Q4 2024 Results, SEMI Reports

After declining in the first half of 2024, electronics sales bounced back later in the year resulting in a 2% annual increase. Electronics sales grew 4% YoY in Q4 2024 and are expected to see a 1% YoY increase in Q1 2025 impacted by seasonality. Integrated circuit (IC) sales rose by 29% YoY in Q4 2024 and continued growth is expected in Q1 2025 with a 23% increase YoY as AI-fueled demand continues boosting shipments of high-performance computing (HPC) and datacenter memory chips.

Similar to electronics sales, semiconductor capital expenditures (CapEx) decreased in the first half of 2024 but saw a strong rebound, particularly in the fourth quarter, resulting in 3% annual growth by the end of 2024. Memory-related CapEx continued to lead the growth surging 53% quarter-on-quarter (QoQ) and 56% YoY in Q4 2024. Non-memory CapEx also edged up in Q4 2024 showing 19% QoQ and 17% YoY improvement. Total CapEx is expected to remain strong in Q1 2025, growing 16% relative to the same period of the previous year on the strength of investments to support high bandwidth memory (HBM) capacity additions for AI deployment.

The semiconductor capital equipment segment remained resilient primarily due to increased investments into expanding leading-edge logic, advanced packaging and HBM capacity. Wafer fab equipment (WFE) spending increased 14% YoY and 8% QoQ in Q4 2024. Quarterly WFE billings are expected to be around $26 billion in Q1 2025. China’s investment continues to play a significant role in the WFE market but started to subside by end of the year. Additionally, back-end equipment showed strong increases in Q4 2024 with the Test segment logging 5% QoQ growth and an impressive 55% YoY increase for the quarter, while the Assembly and Packaging segment experienced a YoY increase of 15%. Both segments are expected to show similar QoQ growth between 6-8% in Q1 2025.

In Q4 2024, installed wafer fab capacity surpassed a record 42 million wafers per quarter worldwide (in 300mm wafer equivalent), and capacity is projected to reach nearly 42.7 million in Q1 2025. Foundry and Logic-related capacity continues to show stronger increases, growing 2.3% QoQ in Q4 2024, and the segment is projected to rise 2.1% in Q1 2025 driven by capacity expansion for advanced nodes. Memory capacity increased 1.1% in Q4 2024 and is forecasted to remain at the same level in Q1 2025 driven by strong demand for HBM.

“Despite seasonality and the challenges of macroeconomic uncertainty, momentum in AI-driven investments continues to fuel expansion across key segments, including memory, capital expenditures, and wafer fab equipment,” said Clark Tseng, Senior Director of Market Intelligence at SEMI. “Looking forward for 2025, the industry remains cautiously optimistic, with robust growth prospects driven by ongoing demand for high-performance computing and data center buildout.”

“As we begin the year, our expectation is for stronger performance in the second half, with semiconductor sales anticipated to remain flat sequentially in the first half, followed by a notable double-digit increase in the latter half,” said Boris Metodiev, Director of Market Analysis at TechInsights. “Inventory challenges persist for discrete, analog, and optoelectronic manufacturers, which will need to be addressed before we can expect widespread growth to resume.” 

The Semiconductor Manufacturing Monitor (SMM) report provides end-to-end data on the worldwide semiconductor manufacturing industry. The report highlights key trends based on industry indicators including capital equipment, fab capacity, and semiconductor and electronics sales, along with a capital equipment market forecast. The SMM report also contains two years of quarterly data and a one-quarter outlook for the semiconductor manufacturing supply chain including leading IDM, fabless, foundry, and OSAT companies. An SMM subscription includes quarterly reports.

Download a sample of the Semiconductor Manufacturing Monitor report

For more information on the report or to subscribe, please contact the SEMI Market Intelligence Team at mktstats@semi.org. Details on SEMI market data are available at SEMI Market Data.  

About SEMI

SEMI® is the global industry association connecting over 3,000 member companies and 1.5 million professionals worldwide across the semiconductor and electronics design and manufacturing supply chain. We accelerate member collaboration on solutions to top industry challenges through Advocacy, Workforce Development, Sustainability, Supply Chain Management and other programs. Our SEMICON® expositions and events, technology communities, standards and market intelligence help advance our members’ business growth and innovations in design, devices, equipment, materials, services and software, enabling smarter, faster, more secure electronics. Visit www.semi.org, contact a regional office, and connect with SEMI on LinkedIn and X to learn more.

Association Contact
Sherrie Gutierrez/SEMI
Phone: 1.831.889.3800
Email: sgutierrez@semi.org